Porcine endogenous retroviruses inhibit human immune cell function: Risk for xenotransplantation?

Virology

Volumn 268, Issue 1, 2000, Pages 87-93

  Tacke, Stefan J ^a   Kurth, Reinhard ^a   Denner, Joachim ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNOMODULATION; LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; SWINE; VIRUS PARTICLE; XENOTRANSPLANTATION;

ANIMALIA; MAMMALIA; PORCINE ENDOGENOUS RETROVIRUS; RNA VIRUSES; SUIDAE; SUS SCROFA; UNIDENTIFIED RETROVIRUS;

EID: 0034050808     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0149     Document Type: Article

References (50)

1. Akiyoshi D. E., Denaro M., Zhu H., Greenstein J. L., Banerjee P., Fishman J. A. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J. Virol. 72:1998;4503-4507.
2. Allan J. S., Broussard S. R., Michaels M. G., Starzl T. E., Leighton K. L., Whitehead E. M., Comuzzie A. G., Lanford R. E., Leland M. M., Switzer W. M., Heneine W. Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res. Hum. Retroviruses. 14:1998;821-824.
3. Armstrong J. A., Porterfield J. S., De Madrid A. T. C-type virus particles in pig kidney cell lines. J. Gen. Virol. 10:1971;195-198.
4. Bach F. H., Fishman J. A., Daniels N., Proimos J., Anderson B., Carpenter C. B., Forrow L., Robson S. C., Fineberg H. V. Uncertainty in xenotransplantation: Individual benefit versus collective risk. Nature Med. 4:1998;141-144.
5. Bouillant A. M. P., Greig A. S., Lieber M. M., Todaro G. J. Type C virus production by a continuous line of pig oviduct cells (PFT). J. Gen. Virol. 27:1975;173-180.
6. Breese S. S. Jr. Virus-like particles occurring in cultures of stable pig kidney cell lines. Arch. Ges. Virusforsch. 30:1970;401-404.
7. Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Saag M. S., Schooley R. T., Thompson M. A., Vella S., Yeni P. G., Volberding P. A. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. J. Am. Med. Assoc. 277:1997;1962-1969.
8. Chan D. C., Kim P. S. HIV entry and its inhibition. Cell. 93:1998;681-684.
9. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 230:1985;453-455.
10. Cooper D. K. C., Ye Y., Rolf L. L. j., Zuhdi N. The pig as potential organ donor for man. Cooper D. K. C., Kemp E., Platt J. L., White D. J. G. Xenotransplantation. 1997;Springer Verlag, Berlin.
11. Denner J. Immunosuppression by oncogenic retroviridae. Zschiesche W. Immune Modulation by Infectious Agents. 1987;140-201 Gustav Fischer Verlag, Jena.
12. Denner J. Expression of the human endogenous retrovirus HERV-K in human tissues: Implications for its role in physiological processes and tumorigenesis. J. Mol. Med. 76:1998a;B4.
13. Denner J. Immunosuppression by retroviruses: Implications for xenotransplantation. Ann. N. Y. Acad. Sci. 862:1998b;75-86.
14. Denner J., Norley S., Kurth R. The immunosuppressive peptide of HIV-1: Functional domains and immune response in AIDS patients. AIDS. 8:1994;1063-1072.
15. Denner J., Persin C., Vogel T., Haustein D., Norley S., Kurth R. The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:1996;442-450.
16. Denner J., Wunderlich V., Bierwolf D. Suppression of human lymphocyte mitogen response by disrupted primate retroviruses of type C (baboon endogenous virus) and type D (PMFV). Acta Biol. Med. Germ. 39:1980;K19-26.
17. Denner J., Wunderlich V., Bierwolf D. Suppression of human lymphocyte mitogen response by proteins of the type-D retrovirus PMFV. Int. J. Cancer. 37:1986;311-316.
18. Denner J., Wunderlich V., Sydow G. Suppression of human lymphocyte mitogen response by retroviruses of type D. I. Action of highly purified intact and disrupted virus. Arch. Virol. 86:1985;177-186.
19. Fan H. Retroviruses and their role in cancer. Levy J. A. The retroviridae. 1994;313-362 Plenum, New York.
20. Fishman J. A. Xenosis and xenotransplantation: Addressing the infectious risks posed by an emerging technology. Kidney Int. Suppl. 58:1997;S41-45.
21. Frazier M. E. Evidence for retrovirus in miniature swine with radiation-induced leukemia or metaplasia. Arch. Virol. 83:1985;83-97.
22. Gottlieb R. A., Kleinerman E. S., CA O. B., Tsujimoto S., Cianciolo G. J., Lennarz W. J. Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E. J. Immunol. 145:1990;2566-2570.
23. Haraguchi S., Good R. A., Cianciolo G. J., Engelman R. W., Day N. K. Immunosuppressive retroviral peptides: Immunopathological implications for immunosuppressive influences of retroviral infections. J. Leukocyte Biol. 61:1997;654-666.
24. Haraguchi S., Good R. A., Day N. K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today. 16:1995;595-603.
25. Hardy W. D. Feline oncoretroviruses. Levy J. A. The retroviridae. 1993;109-180 Plenum, New York.
26. Hebebrand L. C., Mathes L. E., Olsen R. G. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus. Cancer Res. 37:1977;4532-4533.
27. Heneine W., Tibell A., Switzer W. M., Sandstrom P., Rosales G. V., Mathews A., Korsgren O., Chapman L. E., Folks T. M., Groth C. G. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet. 352:1998;695-699.
28. Hirsch M. S., Phillips S. M., Solnik C., Black P. H., Schwartz R. S., Carpenter C. B. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc. Natl. Acad. Sci. USA. 69:1972;1069-1072.
29. Lieber M. M., Sherr C. J., Benveniste R. E., Todaro G. J. Biologic and immunologic properties of porcine type C viruses. Virology. 66:1975;616-619.
30. Löwer R., Löwer J., Kurth R. The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. USA. 93:1996;5177-5184.
31. Mangeney M., Heidmann T. Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;14920-14925.
32. Martin U., Kiessig V., Blusch J. H., Haverich A., von der Helm K., Herden T., Steinhoff G. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet. 352:1998;692-694.
33. Mathes L. E., Olsen R. G., Hebebrand L. C., Hoover E. A., Schaller J. P., Adams P. W., Nichols W. S. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res. 39:1979;950-955.
34. Montelaro R., Bolognesi D. P. Vaccines against retroviruses. Levy J. A. The retroviridae. 1995;605-656 Plenum, New York.
35. Niekrasz M., Ye Y., Rolf L. L., Zuhdi N., Cooper D. K. The pig as organ donor for man. Transplant. Proc. 24:1992;625-626.
36. Pahwa S., Pahwa R., Saxinger C., Gallo R. C., Good R. A. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc. Natl. Acad. Sci. USA. 82:1985;8198-8202.
37. Pantaleo G., Graziosi C., Fauci A. S. The immunopathogenesis of human immunodeficiency virus infection. New Engl. J. Med. 328:1993;327-335.
38. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W. M., Chapman L. E., Lockey C., Onions D., Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science. 285:1999;1236-1241.
39. Patience C., Patton G. S., Takeuchi Y., Weiss R. A., McClure M. O., Rydberg L., Breimer M. E. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet. 352:1998;699-701.
40. Patience C., Takeuchi Y., Weiss R. A. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3:1997;282-286.
41. Pinter A., Honnen W. J., Tilley S. A., Bona C., Zaghouani H., Gorny M. K., Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63:1989;2674-2679.
42. Ragheb J. A., Anderson W. F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:1994;3220-3231.
43. Ruegg C. L., Monell C. R., Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:1989;3257-3260.
44. Starzl T. E., Fung J., Tzakis A., Todo S., Demetris A. J., Marino I. R., Doyle H., Zeevi A., Warty V., Michaels M. Baboon-to-human liver transplantation. Lancet. 341:1993;65-71.
45. Stevens R. B., Platt J. L. The pathogenesis of hyperacute xenograft rejection. Am. J. Kidney Dis. 20:1992;414-421.
46. Swindle M. M. Defining appropriate health status and management programs for specific-pathogen-free swine for xenotransplantation. Ann. N. Y. Acad. Sci. 862:1998;111-120.
47. Takeuchi Y., Patience C., Magre S., Weiss R. A., Banerjee P. T., Le Tissier P., Stoye J. P. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72:1998;9986-9991.
48. Tissier P. I., Stoye J. P., Takeuchi Y., Patience C., Weiss R. A. Two sets of human-topic pig retrovirus. Nature. 389:1997;681-682.
49. Todaro G. J., Benveniste R. E., Lieber M. M., Sherr C. J. Characterization of a type C virus released from the porcine cell line PK(15). Virology. 58:1974;65-74.
50. Wilson C. A., Wong S., Muller J., Davidson C. E., Rose T. M., Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72:1998;3082-3087.